Medical Treatment Assistance for Hematopoietic Stem Sample Clauses

Medical Treatment Assistance for Hematopoietic Stem. Cells Transplantation: If after the Enrollment Date and before the completion of the Child’s 21st (twenty-first) birth anniversary, the Child and/or Child’s biological sibling/s and/or Child’s biological parent/s (applicable as per the chosen Plan Type) are diagnosed of medical condition/s treatable using the Child’s own Specimen and/or matched unrelated Umbilical Cord Blood Specimen/s from the LifeCell Registry (applicable only to Community Banking Clients) through an approved hematopoietic stem cell transplantation, then LifeCell shall pay as per actual expenses or ₹2,000,000 (INR Two Million only) whichever is lesser, to the Client, in order to offset the costs of such stem cell transplantation. In the event that the Child’s own Specimen and/or Umbilical Cord Blood Specimen/s listed on the LifeCell Registry (applicable only to Community Banking Clients) is either no longer available and/or not a suitable match to the patient for stem cell transplantation (in the written opinion of the patient’s transplant physician), then LifeCell will source alternative matched Umbilical Cord Blood Specimen/s from any public stem cell banks worldwide within 14 (fourteen) days for value not exceeding ₹2,000,000 (INR Two Million only). In case if the matching Umbilical Cord Blood Specimen/s is not found in any public stem cell banks worldwide (applicable only to Community Banking Clients), then in order to support the stem cell transplantation from any other approved stem cell sources (like bone marrow or peripheral blood), LifeCell shall pay as per actual expenses or ₹2,000,000 (INR Two Million only) whichever is lesser, to the Client, in order to offset the costs of such stem cell transplantation.
AutoNDA by SimpleDocs

Related to Medical Treatment Assistance for Hematopoietic Stem

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State. (2) In addition, each Contracting Party shall accord to investors of the other Contracting Party, including in respect of returns on their investments, treatment which shall not be less favourable than that accorded to investors of any third State. (3) The provisions of paragraphs (1) and (2) above shall not be construed so as to oblige one Contracting Party to extend to the investors of the other the benefit of any treatment, preference or privilege resulting from: (a) Any existing or future free trade area, customs unions, monetary union or similar international agreement or other forms of regional cooperation to which one of the Contracting Parties is or may become a party, or (b) Any matter pertaining wholly or mainly to taxation.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Future Treatment of Unallowable Costs Unallowable Costs shall be separately determined and accounted for by Defendants, and Defendants shall not charge such Unallowable Costs directly or indirectly to any contracts with the United States or any State Medicaid program, or seek payment for such Unallowable Costs through any cost report, cost statement, information statement, or payment request submitted by Defendants or any of their subsidiaries or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

  • Regulatory Assistance Provider will permit regulators with jurisdiction over BFA or any BFA Recipient to examine Provider’s activities relating to its performance under this Agreement and the Services. Subject to Section 17.6, Provider will cooperate and provide all information reasonably requested by the regulator in connection with any such examination and provide reasonable assistance and access to all equipment, records, and systems requested by the regulator relating to the Services.

  • CONFIDENTIAL TREATMENT REQUESTED Confidential portions of this document have been redacted and have been separately filed with the Commission.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!